Cargando…

Sex disparities in vitamin D status and the impact on systemic inflammation and survival in rectal cancer

BACKGROUND: We reported previously that rectal cancer patients given curative-intent chemotherapy, radiation, and surgery for non-metastatic disease had enhanced risk of metastatic progression and death if circulating levels of 25-hydroxyvitamin D [25(OH) D] were low. Here we investigated whether th...

Descripción completa

Detalles Bibliográficos
Autores principales: Abrahamsson, Hanna, Meltzer, Sebastian, Hagen, Vidar Nyløkken, Johansen, Christin, Bousquet, Paula A., Redalen, Kathrine Røe, Ree, Anne Hansen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111928/
https://www.ncbi.nlm.nih.gov/pubmed/33975557
http://dx.doi.org/10.1186/s12885-021-08260-2
_version_ 1783690593299333120
author Abrahamsson, Hanna
Meltzer, Sebastian
Hagen, Vidar Nyløkken
Johansen, Christin
Bousquet, Paula A.
Redalen, Kathrine Røe
Ree, Anne Hansen
author_facet Abrahamsson, Hanna
Meltzer, Sebastian
Hagen, Vidar Nyløkken
Johansen, Christin
Bousquet, Paula A.
Redalen, Kathrine Røe
Ree, Anne Hansen
author_sort Abrahamsson, Hanna
collection PubMed
description BACKGROUND: We reported previously that rectal cancer patients given curative-intent chemotherapy, radiation, and surgery for non-metastatic disease had enhanced risk of metastatic progression and death if circulating levels of 25-hydroxyvitamin D [25(OH) D] were low. Here we investigated whether the association between the vitamin D status and prognosis pertains to the general, unselected population of rectal cancer patients. METHODS: Serum 25(OH) D at the time of diagnosis was assessed in 129 patients, enrolled 2013–2017 and representing the entire range of rectal cancer stages, and analyzed with respect to season, sex, systemic inflammation, and survival. RESULTS: In the population-based cohort residing at latitude 60°N, 25(OH) D varied according to season in men only, who were overrepresented among the vitamin D-deficient (< 50 nmol/L) patients. Consistent with our previous findings, the individuals presenting with T4 disease had significantly reduced 25(OH) D levels. Low vitamin D was associated with systemic inflammation, albeit with distinct modes of presentation. While men with low vitamin D showed circulating markers typical for the systemic inflammatory response (e.g., elevated erythrocyte sedimentation rate), the corresponding female patients had elevated serum levels of interleukin-6 and the chemokine (C-X-C motif) ligand 7. Despite disparities in vitamin D status and the potential effects on disease attributes, significantly shortened cancer-specific survival was observed in vitamin D-deficient patients irrespective of sex. CONCLUSION: This unselected rectal cancer cohort confirmed the interconnection of low vitamin D, more advanced disease presentation, and poor survival, and further suggested it may be conditional on disparate modes of adverse systemic inflammation in men and women. TRIAL REGISTRATION: ClinicalTrials.govNCT01816607; registration date: 22 March 2013. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-021-08260-2.
format Online
Article
Text
id pubmed-8111928
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-81119282021-05-11 Sex disparities in vitamin D status and the impact on systemic inflammation and survival in rectal cancer Abrahamsson, Hanna Meltzer, Sebastian Hagen, Vidar Nyløkken Johansen, Christin Bousquet, Paula A. Redalen, Kathrine Røe Ree, Anne Hansen BMC Cancer Research Article BACKGROUND: We reported previously that rectal cancer patients given curative-intent chemotherapy, radiation, and surgery for non-metastatic disease had enhanced risk of metastatic progression and death if circulating levels of 25-hydroxyvitamin D [25(OH) D] were low. Here we investigated whether the association between the vitamin D status and prognosis pertains to the general, unselected population of rectal cancer patients. METHODS: Serum 25(OH) D at the time of diagnosis was assessed in 129 patients, enrolled 2013–2017 and representing the entire range of rectal cancer stages, and analyzed with respect to season, sex, systemic inflammation, and survival. RESULTS: In the population-based cohort residing at latitude 60°N, 25(OH) D varied according to season in men only, who were overrepresented among the vitamin D-deficient (< 50 nmol/L) patients. Consistent with our previous findings, the individuals presenting with T4 disease had significantly reduced 25(OH) D levels. Low vitamin D was associated with systemic inflammation, albeit with distinct modes of presentation. While men with low vitamin D showed circulating markers typical for the systemic inflammatory response (e.g., elevated erythrocyte sedimentation rate), the corresponding female patients had elevated serum levels of interleukin-6 and the chemokine (C-X-C motif) ligand 7. Despite disparities in vitamin D status and the potential effects on disease attributes, significantly shortened cancer-specific survival was observed in vitamin D-deficient patients irrespective of sex. CONCLUSION: This unselected rectal cancer cohort confirmed the interconnection of low vitamin D, more advanced disease presentation, and poor survival, and further suggested it may be conditional on disparate modes of adverse systemic inflammation in men and women. TRIAL REGISTRATION: ClinicalTrials.govNCT01816607; registration date: 22 March 2013. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-021-08260-2. BioMed Central 2021-05-11 /pmc/articles/PMC8111928/ /pubmed/33975557 http://dx.doi.org/10.1186/s12885-021-08260-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Abrahamsson, Hanna
Meltzer, Sebastian
Hagen, Vidar Nyløkken
Johansen, Christin
Bousquet, Paula A.
Redalen, Kathrine Røe
Ree, Anne Hansen
Sex disparities in vitamin D status and the impact on systemic inflammation and survival in rectal cancer
title Sex disparities in vitamin D status and the impact on systemic inflammation and survival in rectal cancer
title_full Sex disparities in vitamin D status and the impact on systemic inflammation and survival in rectal cancer
title_fullStr Sex disparities in vitamin D status and the impact on systemic inflammation and survival in rectal cancer
title_full_unstemmed Sex disparities in vitamin D status and the impact on systemic inflammation and survival in rectal cancer
title_short Sex disparities in vitamin D status and the impact on systemic inflammation and survival in rectal cancer
title_sort sex disparities in vitamin d status and the impact on systemic inflammation and survival in rectal cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111928/
https://www.ncbi.nlm.nih.gov/pubmed/33975557
http://dx.doi.org/10.1186/s12885-021-08260-2
work_keys_str_mv AT abrahamssonhanna sexdisparitiesinvitamindstatusandtheimpactonsystemicinflammationandsurvivalinrectalcancer
AT meltzersebastian sexdisparitiesinvitamindstatusandtheimpactonsystemicinflammationandsurvivalinrectalcancer
AT hagenvidarnyløkken sexdisparitiesinvitamindstatusandtheimpactonsystemicinflammationandsurvivalinrectalcancer
AT johansenchristin sexdisparitiesinvitamindstatusandtheimpactonsystemicinflammationandsurvivalinrectalcancer
AT bousquetpaulaa sexdisparitiesinvitamindstatusandtheimpactonsystemicinflammationandsurvivalinrectalcancer
AT redalenkathrinerøe sexdisparitiesinvitamindstatusandtheimpactonsystemicinflammationandsurvivalinrectalcancer
AT reeannehansen sexdisparitiesinvitamindstatusandtheimpactonsystemicinflammationandsurvivalinrectalcancer